For now the bleeding has stopped and it enjoyed a positive day for the market yesterday to start the week. This is still in the buy zone and a company with great fundamentals and does not miss on earnings, although I am not a fan of their fees, they still have a forbiddable track record and brand that is known around the world. I suspect they will have no issue recovering from this decline.